Lange BJ - Search Results

1

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.

Pollard JA, Alonzo TA, Gerbing RB, Ho PA, Zeng R, Ravindranath Y, Dahl G, Lacayo NJ, Becton D, Chang M, Weinstein HJ, Hirsch B, Raimondi SC, Heerema NA, Woods WG, Lange BJ, Hurwitz C, Arceci RJ, Radich JP, Bernstein ID, Heinrich MC, Meshinchi S. Pollard JA, et al. Among authors: lange bj. Blood. 2010 Mar 25;115(12):2372-9. doi: 10.1182/blood-2009-09-241075. Epub 2010 Jan 7. Blood. 2010. PMID: 20056794 Free PMC article.

2

Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group.

Woods WG, Barnard DR, Alonzo TA, Buckley JD, Kobrinsky N, Arthur DC, Sanders J, Neudorf S, Gold S, Lange BJ. Woods WG, et al. Among authors: lange bj. J Clin Oncol. 2002 Jan 15;20(2):434-40. doi: 10.1200/JCO.2002.20.2.434. J Clin Oncol. 2002. PMID: 11786571 Clinical Trial.

3

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.

Lange BJ, Bostrom BC, Cherlow JM, Sensel MG, La MK, Rackoff W, Heerema NA, Wimmer RS, Trigg ME, Sather HN; Children's Cancer Group. Lange BJ, et al. Blood. 2002 Feb 1;99(3):825-33. doi: 10.1182/blood.v99.3.825. Blood. 2002. PMID: 11806983 Free article. Clinical Trial.

4

Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: a report from the Children's Cancer Group.

Alonzo TA, Kobrinsky NL, Aledo A, Lange BJ, Buxton AB, Woods WG. Alonzo TA, et al. Among authors: lange bj. J Pediatr Hematol Oncol. 2002 Nov;24(8):627-35. doi: 10.1097/00043426-200211000-00006. J Pediatr Hematol Oncol. 2002. PMID: 12439034 Clinical Trial.

5

Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.

Sievers EL, Lange BJ, Alonzo TA, Gerbing RB, Bernstein ID, Smith FO, Arceci RJ, Woods WG, Loken MR. Sievers EL, et al. Among authors: lange bj. Blood. 2003 May 1;101(9):3398-406. doi: 10.1182/blood-2002-10-3064. Epub 2002 Dec 27. Blood. 2003. PMID: 12506020 Free article.

6

Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.

Gamis AS, Woods WG, Alonzo TA, Buxton A, Lange B, Barnard DR, Gold S, Smith FO; Children's Cancer Group Study 2891. Gamis AS, et al. J Clin Oncol. 2003 Sep 15;21(18):3415-22. doi: 10.1200/JCO.2003.08.060. Epub 2003 Jul 28. J Clin Oncol. 2003. PMID: 12885836 Clinical Trial.

7

Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group.

Dusenbery KE, Howells WB, Arthur DC, Alonzo T, Lee JW, Kobrinsky N, Barnard DR, Wells RJ, Buckley JD, Lange BJ, Woods WG. Dusenbery KE, et al. Among authors: lange bj. J Pediatr Hematol Oncol. 2003 Oct;25(10):760-8. doi: 10.1097/00043426-200310000-00004. J Pediatr Hematol Oncol. 2003. PMID: 14528097

8

Progenitor cell involvement is predictive of response to induction chemotherapy in paediatric acute myeloid leukaemia.

Johnston DL, Meshinchi S, Opheim KE, Pallavicini MG, Feusner J, Woods WG, Lange BJ, Radich JP, Bernstein ID. Johnston DL, et al. Among authors: lange bj. Br J Haematol. 2003 Nov;123(3):431-5. doi: 10.1046/j.1365-2141.2003.04633.x. Br J Haematol. 2003. PMID: 14617001 Free article.

9

Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941.

Lange BJ, Dinndorf P, Smith FO, Arndt C, Barnard D, Feig S, Feusner J, Seibel N, Weiman M, Aplenc R, Gerbing R, Alonzo TA. Lange BJ, et al. J Clin Oncol. 2004 Jan 1;22(1):150-6. doi: 10.1200/JCO.2004.04.016. J Clin Oncol. 2004. PMID: 14701777 Clinical Trial.

10

Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival.

Neudorf S, Sanders J, Kobrinsky N, Alonzo TA, Buxton AB, Gold S, Barnard DR, Wallace JD, Kalousek D, Lange BJ, Woods WG. Neudorf S, et al. Among authors: lange bj. Blood. 2004 May 15;103(10):3655-61. doi: 10.1182/blood-2003-08-2705. Epub 2004 Jan 29. Blood. 2004. PMID: 14751924 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters